Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: A meta-analysis

Table 1 Characteristics of the included studies in the meta-analysis

No.	Authors and year of publication	Country	Patients (n)		Treatment group		Control group
			Treatment	Control	Pre-op	Post-op	Pre-op	Post-op
1	Schuhmacher et al[15], 2010	Germany	72	72	5-FU + DDP	None	None	None
2	Boige et al[11], 2011	France	113	111	FP	FP	None	None
3	Cunningham et al[12], 2006	United Kingdom	250	253	ECF	ECF	None	None
4	Hartgrink et al[13], 2004	Holland	27	29	FAMTX		None	None
5	Zhang et al[17], 2004	China	37	54	IV (no details)		None	None
6	Kobayashi et al[14], 2000	Japan	91	80	5-FU (oral)	CT	None	None
7	Wang et al[16], 2000	China	30	30	5-FU (oral)		None	None

5-FU: 5-fluorouracil; DDP: Cisplatin; FP: 5-FU/cisplatin; ECF: Epirubicin/cyclophosphamide/5-FU; FAMTX: 5-FU/adriamycin/methotrexate; CT: Chemotherapy; IV: Intravenous; Pre-op: Preoperative; Post-op: Postoperative.